THE FEW REMAINING (IMPOSSIBLE) CASES
|
|
- Augusta Fletcher
- 6 years ago
- Views:
Transcription
1 THE FEW REMAINING (IMPOSSIBLE) CASES AG Holley 60 th Anniversary Celebration AG Holley State Hospital Lantana, FL July 21, 2010 Lee B. Reichman, MD, MPH AG Holley 60th Anniversary Celebration 1
2 TB Historical Permutation 17th - 18th centuries TB took 1 in 5 adult lives one billion people died d of TB Next decade million new infections 90 million new cases 30 million deaths More people died from TB last year than any year in history TB Could Be Eliminated Because We Understand It We know its: Cause Transmission Treatment Prevention AG Holley 60th Anniversary Celebration 2
3 TB Isn t Eliminated Because: Nobody seems to care This wouldn t be tolerated for any other disease Deaths Due To: TB (annually) 1,800,000 SARS 813 H1N1 18,311 Anthrax 5 Mad Cow Disease 1(Cow) Smallpox 0 AG Holley 60th Anniversary Celebration 3
4 Latest Global TB Estimates All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Extensively drug-resistant TB (XDR-TB) HIV-associated TB Estimated number of cases 9.4 million (139 per 100,000) 440,000 (3.6% of cases) ~50, % of MDR (58 countries) 1.4 million (15%) Estimated number of deaths 1.8 million (27 per 100,000) ~150,000 (Updated June 2010) ~30, ,000 The Global Burden of TB, Estimated 9.4 million new cases 7.9 million (84%) in Asia and sub-saharan Africa 8% of new TB cases are HIV-infected 22% of new TB cases in Africa are HIV-infected 1.8 million people died of TB (98% of deaths in developing world) 456,000 HIV-infected patients 1/3 of the world is infected with M. tb (2 billion people) AG Holley 60th Anniversary Celebration 4
5 Estimated Numbers of New Cases, 2006 Estimated number of new TB cases (all forms) No estimate or more The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved Estimated TB Burden, high burden countries # of new cases # of new cases 1. India 1,933, Vietnam 149, China 1,311,000, Kenya 141, Indonesia 534, Tanzania 123, South Africa 454, Uganda 106, Nigeria 450, Brazil 94, Bangladesh 351, Mozambique 93, Ethiopia 306, Thailand 90, Pakistan 292, Myanmar 83, Philippines 248, Zimbabwe 74, DR Congo 237, Cambodia 71, Russia 153, Afghanistan 42,000 TOTAL: 7,335,000 AG Holley 60th Anniversary Celebration 5
6 Global TB Control: Background 1991 World Health Assembly recognized the growing g importance of TB as a public health problem A new framework for TB control was developed A global strategy called DOTS was introduced (originally stood for Directly Observed Treatment, Short Course) International TB Control Strategy DOTS : Political commitment Case detection using sputum microscopy among persons seeking care for prolonged cough Standardized short-course chemotherapy under proper case-management conditions including DOT Regular drug supply Standardized recording and reporting system that allows assessment of individual patients as well as overall program performance AG Holley 60th Anniversary Celebration 6
7 World Health Assembly Targets for Global TB Control By 2000: Detect 70% of all new sputum smear-positive cases every year Successfully treat 85% of these cases The slow progress of many countries prior to 2000 led to the revision of the target year to targets narrowly missed: Case detection: 63%; treatment success: 85% Difficulties of managing TB in Africa and Eastern Europe linked to HIV/AIDS and drug resistance International TB Control Strategy Stop TB Strategy: current 1. Pursue high-quality DOTS expansion and enhancement 2. Address TB/HIV, MDR-TB and other challenges 3. Contribute to health system strengthening 4. Engage all care providers 5. Empower people with TB, and communities 6. Enable and promote research AG Holley 60th Anniversary Celebration 7
8 Emergence of worst-case TB scenarios Co-infection between TB and HIV Multidrug-resistant TB (MDR-TB) Resistance to isoniazid and rifampin the 2 most powerful anti-tb drugs Extensively-drug resistant TB (XDR-TB) MDR-TB plus resistance to any fluoroquinolone l and at least 1 second-line injectable (AMI, KAN, CAP) The Global Burden of TB/HIV 1/3 of 33 million people living with HIV/AIDS co-infected with TB (>10 million people) Without treatment, 90% will die within months HIV and TB form a lethal combination, each speeding the other's progress TB is the leading cause of death among HIVpositive people (up to 50% of all patients worldwide) AG Holley 60th Anniversary Celebration 8
9 Co-Existence of HIV & TB infection TB Infection HIV Infection 10% per lifetime 10% per year.0017% per year Risk of Active TB Estimated HIV Prevalence in New TB Cases, 2006 HIV prevalence in TB cases, (%) No estimate or more The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved AG Holley 60th Anniversary Celebration 9
10 MDRTB/XDRTB - The Big Problem! 500,000 new MDR-TB cases estimated annually XDR-TB in 58 countries <5% of estimated MDR-TB cases detected in % of MDR-TB cases projected to be treated in 2008 and 3% only under GLC standards About 85% of the global MDR-TB burden in 27 countries Sources: Global TB Report, 2008 and IV Global DRS Report, 2008 Use of One Drug Knowingly or Unknowingly Sensitive bacilli killed Resistant bacilli multiply unimpeded Resistant bacilli become dominant Efficacy of Fluroquinolones in TB and non Efficacy of Fluroquinolones in TB and non TB infection suggests increases in cross species resistance will increase as has already been shown AG Holley 60th Anniversary Celebration 10
11 Distribution of countries and territories reporting at least one case of XDR-TB as of January 2010 Source: WHO M/XDR-TB, 2010 Global Report Distribution of proportion of MDR-TB among new TB cases, Source: WHO M/XDR-TB, 2010 Global Report AG Holley 60th Anniversary Celebration 11
12 Distribution of proportion of MDR-TB among previously treated TB cases, Source: WHO M/XDR-TB, 2010 Global Report Estimated proportion and number of MDR-TB cases in the 27 MDR-TB high burden countries, 2008 Source: WHO M/XDR-TB, 2010 Global Report AG Holley 60th Anniversary Celebration 12
13 Unsexy Tuberculosis Concern and attention re: XDR-TB is appropriate, but skips the more important message XDR-TB, MDR-TB, and drug-sensitive tuberculosis are all the same disease The only difference is that MDR-TB is drug-sensitive tuberculosis modified by inappropriate treatment or drug taking, and XDR-TB is MDR-TB thus modified We need to recognize that there are more than 9,000,000 new active drugsensitive cases of tuberculosis globally that could be feeding drug resistance It might be a less sexy concept, but they all must be appropriately treated with current strategies (as well as new diagnostics, drugs, vaccines, and proper infection control measures) to avoid preventable MDR-TB and XDR- TB, which are always lurking Preventing active, drug-sensitive tuberculosis, or treating it properly, should be everybody s priority; it is the only way to prevent MDR-TB and XDR-TB Reichman, LB The Lancet, 2009 AG Holley 60th Anniversary Celebration 13
14 AG Holley 60th Anniversary Celebration 14
15 AG Holley 60th Anniversary Celebration 15
16 Inadequacies in Physician Practices Major Recurring Practice Delays in diagnosis and errors in treatment Resulting In Increased risk and likelihood of disease transmission More advanced and complicated disease Lengthened hospital stays Increased medical costs Development of MDR-TB and XDR-TB AG Holley 60th Anniversary Celebration 16
17 International Standard for TB Care: Diagnosis All persons with otherwise unexplained cough lasting for 2-3 weeks or more should be evaluated for tuberculosis AG Holley 60th Anniversary Celebration 17
18 International Standard for TB Care: Diagnosis Microbiological evaluation (smear ± culture) is essential for all patients (including children, extra-pulmonary, and persons with radiographic abnormalities) International Standard for TB Care: Treatment The provider is responsible for prescribing an adequate regimen and ensuring adherence AG Holley 60th Anniversary Celebration 18
19 International Standard for TB Care: Treatment A patient-centered, individualized approach to treatment should be developed for all patients. A central element is direct observation by a treatment supporter. Progress Towards Global Targets 70/85 by Case detection rate: 63% (target 70%) 2006 Treatment success: 85% (target 85%) AG Holley 60th Anniversary Celebration 19
20 Where Are The Missing Cases? They are not detected due to poor laboratory capacity Where Are The Missing Cases? At home, if services are not accessible AG Holley 60th Anniversary Celebration 20
21 Where Are The Missing Cases? In other un-connected public systems (prisons) Where Are The Missing Cases? In the private sector AG Holley 60th Anniversary Celebration 21
22 Patient Involvement in Medical Care Patients and their families have become increasingly gy involved and influential in all aspects of medical care In the mid-eighties, as the first anti-viral drugs for treating AIDS were being developed, activists demanded to participate in the design of clinical trials directed by the National Institutes of Health and pharmaceutical companies Laypeople now routinely sit on committees on the N.I.H. and on hospitals institutional review boards, which assess the ethicality and scientific merit of clinical trials The Patient s Charter for Tuberculosis Care AG Holley 60th Anniversary Celebration 22
23 The Patient s Charter for Tuberculosis Care Companion document to International Standards Initiated and developed by patients from around the world Outlines rights and responsibilities of people with tuberculosis Affirms that empowerment is catalyst for effective collaboration of the patient with health providers and authorities Patient s Rights You have the right to: Care; Dignity; Information; Choice; Confidence; Justice; Organization; Security Source: Patient s Charter for TB Care, 2006 AG Holley 60th Anniversary Celebration 23
24 Patient s Responsibilities You have the responsibility to: Share information; Follow treatment; Contribute to Community Health; Show Solidarity Source: Patient s Charter for TB Care, 2006 The Global Burden of Tuberculosis NO NEW DRUGS / NO NEW TOOLS Last new drug class specifically for TB - Rifampin i (1968 Europe, 1974 US) Most widely used diagnostic test - Tuberculin (1890) Ineffective most widely used vaccine - BCG (1919) Wouldn t one think that largest killer of any single infection deserves better, newer tools? AG Holley 60th Anniversary Celebration 24
25 Approved & Major Experimental ARV Drugs ( ) ARV Class Approved Experimental Under Investigation Experimental Interrupted NRTI NNRTI PI Entry Inhibitors Integrase Inhibitors Maturation Inhibitors Gene Therapy TOTAL Vitoria MAA, October 2008 TB at a Crossroad of Global TB Control Domestic decline of TB since prior to development of drugs Resurgence of TB during the 1980s and 1990s, largely due to neglect Massive and effective response TB on the radar screen domestically TB on the radar screen internationally AG Holley 60th Anniversary Celebration 25
26 TB Remains a Global Killer Why does TB still infect one-third of the world s population o and remain a global health threat despite the fact that highly cost-effective drugs are available to eradicate it? Challenges in TB Control Insufficient financial and human resources Inadequate healthcare infrastructure Weak laboratory capacity and lack of new rapid diagnostic tools Lack of new drugs that would cure TB in a shorter time Lack of effective vaccine that would prevent TB Poor use of infection control in healthcare settings Minimal social mobilization for TB control and minimal population awareness stigma HIV and MDR/XDR threats AG Holley 60th Anniversary Celebration 26
27 Annik Rouillion Defaulters and Motivation to default is the natural reaction of normal, sensible people: The person who continues to swallow drugs or have injections with complete regularity in the absence of encouragement and help from others is the abnormal one. - Bull IUAT 1972; 47:68-75 AG Holley 60th Anniversary Celebration 27
28 As we cure increasing numbers, the remaining i cases are those most difficult to treat, with impossible social problems, and/or severe, virtually untreatable but still transmissible, drug resistance THE FEW REMAINING CASES This talk has concentrated on the difficult remaining TB cases With DOTS and case management along with funding, interest and involvement in developing new tools and strategies for combating TB we have taken care of the easy ones and Expertise decreases Funding decreases The few remaining cases increase especially in High incidence areas Florida, New York, California, Texas victims of populations that they serve high foreign born, high HIV and high MDR & XDR TB care under specific categorized effective funding AG Holley 60th Anniversary Celebration 28
29 So What is the Answer Either continued failure in the cure of these difficult cases, bouncing in and out of hospitals whenever the utilization review offices stops by or specialized centers such as AG Holley who cost effectively know what they are doing and to fund it We need to set up a major exemption for funding the care of patients who have failed usual treatment, through Medicare and Medicaid It is in everybody s interest to get legislatures out of the TB business - to put TB cases and control as well as specialized care of impossible cases where it belongs such as here TB in the US -1 TABLE. Number and rate* of tuberculosis cases and percentage change, by race/ethnicity --- United States, Race/Ethnicity % change from 2008 to 2009 Population Rat Rat No. No. No. Rate e e Hispanic 3, , ,943,613 48,431,199 Non-Hispanic Black 3, , ,171,750 37,533,254 Asian 3, , ,237,698 13,562,701 White 2, , ,491, ,877,195 Other ,215,205 7,398,669 Unknown Total 12, , ,059, ,803,018 * Per 100,000 population. Data updated as of February 16, Data for 2009 are provisional. Based on U.S. Census population data. Persons included in this category are American Indian/Alaskan Native (2009, n = 102, rate: 4.3 per 100,000; 2008, n = 137, rate: 5.9 per 100,000); Native Hawaiian or other Pacific Islander (2009, n = 80, rate: 18.1 per 100,000; 2008, n = 69, rate: 15.9 per 100,000); and multiple race (2009, n = 40, rate: 0.9 per 100,000; 2008, n = 40, rate: 0.9 per 100,000). - CDC, 2010 AG Holley 60th Anniversary Celebration 29
30 TB in the US -2 FIGURE 1. Rate* of tuberculosis (TB) cases, by state/area --- United States, 2009 SOURCE: National TB Surveillance System. * Per 100,000 population. Data are updated as of February 16, 2010, and are provisional. 19 states had TB case rates of 2.0 (range: ) per 100,000, 20 states had TB case rates of (range: ) per 100,000, and 11 states and the District of Columbia had TB case rates of 4.0 (range: ) per 100, CDC, 2010 TB in the US -3 FIGURE 2. Number and rate* of tuberculosis (TB) cases among U.S.-born and foreign-born persons, by year reported --- United States, SOURCE: National TB Surveillance System. * Per 100,000 population. Data are updated as of February 16, Data for 2009 are provisional. - CDC, 2010 AG Holley 60th Anniversary Celebration 30
31 Tuberculosis Control and Elimination : Cure, Care, and Social Development - 1 Rapid expansion of the standardised approach to tuberculosis diagnosis and treatment that is recommended by WHO allowed more than 36 million people to be cured between 1995 and 2008, averting up to 6 million deaths Tuberculosis remains a severe global public health threat Although the overall target related to the Millenium Development Goals of halting and beginning to reverse the epidemic might have already been reached, the more important long-term elimination target set for 2050 will not be met with present strategies and instruments - Lonnroth, Castro, Chakaya, et al, Lancet, 2010 Tuberculosis Control and Elimination : Cure, Care, and Social Development - 2 Several key challenges persist: Many vulnerable people do not have access to affordable services of sufficient quality Technologies for diagnosis, treatment, and prevention are old and inadequate Multi-drug resistant tuberculosis is a serious threat in many settings HIV/AIDS continues to fuel the tuberculosis epidemic, especially in Africa Other risk factors and underlying social determinants help to maintain tuberculosis - Lonnroth, Castro, Chakaya, et al, Lancet, 2010 AG Holley 60th Anniversary Celebration 31
32 Tuberculosis Control and Elimination : Cure, Care, and Social Development - 3 Acceleration of the decline towards elimination of this disease will need invigorated actions in four broad areas Continued scale-up of early diagnosis and proper treatment for all forms of tuberculosis Development and enforcement of bold health-system policies Establishment of links with the broader development agenda Promotion and intensification of research towards innovations - Lonnroth, Castro, Chakaya, et al, Lancet, 2010 Why do we need to care about TB in the rest of the world? AG Holley 60th Anniversary Celebration 32
33 Our Challenge How to maintain services to those with the disease and prevent the development and transmission to those without TB in a climate of declining resources? What Do We Need To Do? Ask our leaders to encourage: Serious discussions on mechanisms needed to preserve the TB public health infrastructure Determine what resources will be needed to perform TB control, including the level needed (local vs. regional) Identify existing resources and assure proper legal authority and procedures available to assure access to expert care for all Maintain adequate funding for infrastructure including establishing unique funding for particular threats to the public s health AG Holley 60th Anniversary Celebration 33
34 Lessons from Andrew Speaker TB has not gone away, it remains with us, highly prevalent and transmissible Anybody can get tuberculosis, not only poor people, minorities, or the foreign-born TB anywhere is TB everywhere All resistant TB, MDR and XDR TB is preventable by proper TB diagnosis and treatment Good public health is a silent secret, but when there is a small glitch, it becomes major news We desperately need new tools for TB diagnosis and treatment You don t want to sit on an airplane for 8 hours next to an untreated coughing person with any kind of TB, be it drug sensitive, MDR or XDR AG Holley 60th Anniversary Celebration 34
35 INFORMATION LINE TB DOCS ( ) AG Holley 60th Anniversary Celebration 35
Global, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationTHE UNUSUAL SUSPECTS
THE UNUSUAL SUSPECTS Partnerships are the Key to TB Elimination Opening Plenary Northeast TB Controllers Conference Lee B. Reichman, MD, MPH Cleveland, OH October 12, 2011 Reported TB Cases* United States,
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationControlling TB in the era of HIV
Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population
More informationThe United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationTechnology and innovation: Changing dynamics of TB control. Karin Weyer
Technology and innovation: Changing dynamics of TB control Karin Weyer Latest news 1. New tools finally a reality 2. Universal access for all affected from TB 3. Emphasis on early case detection and treatment
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationXDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine
XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationThe American Experience with TB Elimination
Reaching the Goal of TB Elimination by 2035 March 3, 2015 The American Experience with TB Elimination John Jereb, M.D. Medical officer Division of Tuberculosis Elimination National Center for HIV/AIDS,
More informationTuberculosis Epidemiology
Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationWorld Health Organization 2013
World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,
More informationQuestions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs
Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in
More informationName of the presenter
Progress in tuberculosis care: setting the scene for Central Asia Name of the presenter Gombogaram Tsogt, Shalva Gamtsemlidze Quality Health Care Project Global TB estimates All forms of TB greatest number
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationTB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)
TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global
More informationTB EPIDEMIOLOGY: IMPACT ON CHILDREN. Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University
TB EPIDEMIOLOGY: IMPACT ON CHILDREN Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University Robert Koch 1843-1910 Discovered M. tuberculosis 1882 TB deaths
More informationTB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology
TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More information7.5 South-East Asian Region: summary of planned activities, impact and costs
PART II: GLOBAL AND REGIONAL SCENARIOS FOR TB CONTROL 26 215 7.5 South-East Asian Region: summary of planned activities, impact and costs Achievements DOTS expanded rapidly in the South-East Asian Region
More informationFollow-up to the high-level meetings of the United Nations General Assembly on health-related issues
EXECUTIVE BOARD EB44/ 44th session December 08 Provisional agenda item 5.8 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues Ending tuberculosis Report
More informationLa Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012
La Lotta alla Tubercolosi Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland Geneva 19-20 March 2012 Overview of the presentation The global burden of tuberculosis The WHO
More informationWHERE DO WE GO FROM HERE?
WHERE DO WE GO FROM HERE? WHAT WILL BE REQUIRED TO ACHIEVE ZERO DEATHS FROM TUBERCULOSIS? SALMAAN KESHAVJEE, MD, PHD, SCM HARVARD MEDICAL SCHOOL BRIGHAM AND WOMEN S HOSPITAL PARTNERS IN HEALTH INTERNATIONAL
More informationAppendix 3 Sample size and cost of surveys
Appendix 3 Sample size and cost of surveys Here we estimate the sample sizes needed to carry out prevalence of infection and disease, incidence of disease and verbal autopsy surveys in the 22 high burden
More informationTHE Price of a Pandemic 2017
THE Price of a Pandemic 2017 From 2000-2015: 33 million people died because of TB at a global economic cost of $617bn This report was produced the Global TB Caucus, an international network of over 2,000
More informationOverview of the Presentation
Overview of the Presentation Definitions(TBCase, MDR-TB & XDR-TB) Global Tuberculosis (TB,HIV/TB,MDR & XDR)Scenario & Trend Risk factor for TB Natural history of TB Types of TB & Trends of Extra Pulmonary
More informationGLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY
GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY 2018 Context On 26 September 2018, the United Nations (UN) will hold its first highlevel meeting on tuberculosis (TB), at its headquarters in New York. The
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationA Review on Prevalence of TB and HIV Co-infection
Human Journals Review Article May 2015 Vol.:1, Issue:1 All rights are reserved by Jyoti P. Waghmode et al. A Review on Prevalence of TB and HIV Co-infection Keywords: tuberculosis, HIV, co-infection, prevalence
More informationWHAT'S IN A NUMBER? TWO RECENT REPORTS ESTIMATING CHILDHOOD TB CASES.
WHAT'S IN A NUMBER? TWO RECENT REPORTS ESTIMATING CHILDHOOD TB CASES. Helen Jenkins, Peter Dodd, Andrea Cruz Instructor, Brigham and Women's Hospital, Boston, USA Research Associate, University of Sheffield,
More informationThe Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
More informationON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES
ON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES VISION: A WORLD FREE OF TB Zero deaths, disease and suffering due to tuberculosis GOAL: END THE GLOBAL TB EPIDEMIC INDICATORS
More informationTuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control
Tuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control Suvanand Sahu Deputy Executive Director Stop TB Partnership Secretariat Tuberculosis TB epidemic is declining very slowly We
More informationSuraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
More informationWHO Global Task Force on TB Impact Measurement An overview
WHO Global Task Force on TB Impact Measurement An overview Katherine Floyd (WHO/GTB/TME) 3 rd meeting of the TB estimates subgroup Glion-sur-Montreux, 31March 2 April 2015 GLOBAL TB PROGRAMME 1. Broad
More informationTuberculosis Populations at Risk
Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More information2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:
The theme for World TB Day 2014 is Reach the missed 3 million. Every year 3 million people who fall ill with TB are missed by health systems and do not always get the TB services that they need and deserve.
More informationEpidemiology of TB: A Local and National Overview
Epidemiology of TB: A Local and National Overview Sonal S. Munsiff, MD Director, Bureau of Tuberculosis Control NYC Department of Health and Mental Hygiene Medical Officer, DTBE, CDC February 4, 24 Tuberculosis
More informationExpanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination
IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center
More informationMDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT
TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Epidemiology Robert Petrossian July 18, 2012 Robert Petrossian has the following disclosures to make: No conflict of interests No relevant
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationFinding the missing TB cases
Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working
More informationStop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
More informationKenya Perspectives. Post-2015 Development Agenda. Tuberculosis
Kenya Perspectives Post-2015 Development Agenda Tuberculosis SPEAKERS Anna Vassall Anna Vassall is Senior Lecturer in Health Economics at the London School of Hygiene and Tropical Medicine. She is a health
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationMultidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017
Multidrug-/ rifampicinresistant TB (MDR/RR-TB): Update 2017 The global TB situation (1) Estimated incidence, 2016 Estimated number of deaths, 2016 All forms of TB HIV-associated TB Multidrug- / rifampicin-resistant
More informationHow has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH
How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS
More informationSubstance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010
Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Mary Long, MPSH; Heartland Phillip Lindsey, MD; OK State
More informationDrug resistance TB in People Living with HIV: research questions and priorities.
Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,
More informationTB Disease Prevalence Survey - Progress Report
TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationLeaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015
Leaving no one behind in Asia and the Pacific Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015 Number Regional overview of trends in HIV infections and AIDS-related
More informationRecipients of development assistance for health
Chapter 2 Recipients of development assistance for health Both low- and middle-income countries are eligible for development assistance for health (DAH). In addition to income, burden of disease, which
More informationLatest Funding Trends in AIDS Response
Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July
More informationTB Intensive Minneapolis, Minnesota September 23-26, 2008
TB Intensive Minneapolis, Minnesota September 23-26, 2008 TB in the Foreign-Born Population: Background and Demographic Overview Marge Higgins, LSW September 24, 2008 TB in the Foreign-Born Population
More informationRevitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment
17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationDRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION
JOURNAL OF PREVENTIVE MEDICINE 2008; 16(3-4): 3-9 Inviting Editorial DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION Harshad Thakur Centre for Health Policy, Planning and Management,
More informationProgress, challenges and the way forward in ASEAN Member States
MDG 6A: Combating HIV/AIDS Progress, challenges and the way forward in ASEAN Member States Dr Bob Verbruggen UNAIDS Regional Support Team ASEAN Multi-Sectoral Workshop on MDGs July 30-31 2012, Yangon,
More informationInternational Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007
TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National
More informationTuberculosis: The Big Picture And Challenge of Drug-resistance
5 th APHL National Conference on Laboratory Aspects of Tuberculosis August 11-13, 2008 San Diego, California Tuberculosis: The Big Picture And Challenge of Drug-resistance RADM Kenneth G. Castro, M.D.
More informationDEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
More informationRAPID DIAGNOSIS AND TREATMENT OF MDR-TB
RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed
More informationHIV as a Risk Factor for TB Henry Pacheco, MD November 13, 2008
Tuberculosis Updates for Clinicians San Antonio, Texas November 13, 2008 HIV as a Risk Factor for TB Henry Pacheco, MD November 13, 2008 HIV as a Risk Factor for TB Tuberculosis Update for the Clinician
More informationEPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN
EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN Anneke C. Hesseling Professor in Paediatrics and Child Health Director: Desmond Tutu TB center Stellenbosch University 11 September 11 th International
More informationDeveloping a Rights-Based Approach to Prevention and Treatment of Tuberculosis in India
University of Chicago Center in Delhi Developing a Rights-Based Approach to Prevention and Treatment of Tuberculosis in India Organizers United States: Evan Lyon, MD Assistant Professor of Medicine, Department
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationAchieve universal primary education
GOAL 2 Achieve universal primary education TARGET Ensure that, by 2015, children everywhere, boys and girls alike, will be able to complete a full course of primary schooling Considerable progress has
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationWhat we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat
3 rd Global HIV/AIDS Surveillance Meeting What we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat Peter D Ghys (UNAIDS) Daniel Low-Beer (WHO) Irum Zaidi
More informationCenter for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home
Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public
More informationTB Disease Prevalence Survey - Overview and Introduction of the TF
TB Disease Prevalence Survey - Overview and Introduction of the TF Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationaids in asia and the pacific
HIV AIDS AND DEVELOPMENT IN ASIA AND THE PACIFIC a lengthening shadow aids in asia and the pacific World Health Organization Regional Offices for South East Asia and the Western Pacific Region 9 10 OCTOBER
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationC R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership
C R E A E Consortium to Respond Effectively to the AIDS-TB Epidemic An International Research Partnership Supported by the Bill and Melinda Gates Foundation http://www.tbhiv-create.org Overview What is
More informationRevised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme 1 OUTLINE OF PRESENTATION Introduction Burden Of The Disease Evolution Of RNTCP Goals And Objectives Of RNTCP DOTS Stop TB Strategy Organization RNTCP Endorsed
More informationExperiences on Workforce Development in Other Regions
Experiences on Workforce Development in Other Regions The USA Experience John MacArthur, MD, MPH (EIS 98) Director Thailand MOPH US CDC Collaboration CDC/Southeast Asia Regional Office Epidemic Intelligence
More informationDrug-resistant Tuberculosis
page 1/15 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Level 2 - Details on Drug-resistant Tuberculosis 1. What is tuberculosis and why is it
More informationToyako Framework for Action on Global Health - Report of the G8 Health Experts Group -
Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group - 8 July 2008 This report is the recommendation from the G8 Health Experts Group to the G8 leaders. I Introduction 1.
More informationMaternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009
Maternal and Neonatal Tetanus Elimination by 2012 Yes, We Can! Global Immunization Meeting 18 th February 2009 OUTLINE Can we eliminate MNT by 2012? Can MNTE contribute to MDG4? Can TT-SIAs help to deliver
More informationEnding the AIDS epidemic by 2030
Ending the AIDS epidemic by 2030 Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific for the UNAIDS Regional Management Meeting 25 th October 2014 Number Regional overview of trends
More informationHealth for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
More informationANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012
ANNUAL TUBERCULOSIS REPORT OREGON 211 Oregon Health Authority Public Health Division TB Program November 212 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-211... page
More informationSix things you need to know
UNAIDS Report 2010 MDG 6 Six things you need to know about the AIDS response today UNAIDS Report 2010 MDG 6 Six things you need to know about the AIDS response today MDG6: Combat HIV/AIDS, Malaria and
More information